In vitro function of platelets treated with ultraviolet C light for pathogen inactivation: A comparative study with nonirradiated and gamma-irradiated platelets

Transfusion

Volumn 55, Issue 6, 2015, Pages 1169-1177

  Tynngård, Nahreen ^a   Trinks, Marie ^a   Berlin, Gösta ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CONTROLLED STUDY; ELASTICITY; FLOW MEASUREMENT; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; OSCILLATION; THROMBOCYTE; THROMBOELASTOGRAPHY; ULTRAVIOLET C RADIATION; ADULT; ADVERSE EFFECTS; ANALYSIS; APOPTOSIS; BLOOD; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TEST; BLOOD STORAGE; BLOODBORNE BACTERIUM; COMPARATIVE STUDY; GAMMA RADIATION; GLUCOSE BLOOD LEVEL; OSMOTIC PRESSURE; PH; PHYSIOLOGY; RADIATION RESPONSE; THROMBOCYTE ACTIVATION; THROMBOCYTE VOLUME; ULTRAVIOLET RADIATION; VIRUS INACTIVATION;

CARBON DIOXIDE; GLUCOSE BLOOD LEVEL; OXYGEN; PADGEM PROTEIN; PHOSPHATIDYLSERINE;

ADULT; APOPTOSIS; BLOOD COAGULATION TESTS; BLOOD GLUCOSE; BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD-BORNE PATHOGENS; CARBON DIOXIDE; ELASTICITY; GAMMA RAYS; GLYCOLYSIS; HUMANS; HYDROGEN-ION CONCENTRATION; MEAN PLATELET VOLUME; OSMOTIC PRESSURE; OXYGEN; P-SELECTIN; PHOSPHATIDYLSERINES; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; ULTRAVIOLET RAYS; VIRUS INACTIVATION;

EID: 84930867737     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12963     Document Type: Article

References (44)

1. Stroncek DF, Rebulla P. Platelet transfusions. Lancet 2007;370:427-38.
2. Hervig T, Seghatchian J, Apelseth TO. Current debate on pathogen inactivation of platelet concentrates - to use or not to use? Transfus Apher Sci 2010;43:411-4.
3. Dumont LJ, Kleinman S, Murphy JR, et al. Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion 2010;50:589-99.
4. Pearce S, Rowe GP, Field SP. Screening of platelets for bacterial contamination at the Welsh Blood Service. Transfus Med 2011;21:25-32.
5. Grass JA, Wafa T, Reames A, et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood 1999;93:3140-7.
6. Mohr H, Gravemann U, Bayer A, et al. Sterilization of platelet concentrates at production scale by irradiation with short-wave ultraviolet light. Transfusion 2009;49:1956-63.
7. Seghatchian J, Tolksdorf F. Characteristics of the THERAFLEX UV-Platelets pathogen inactivation system - an update. Transfus Apher Sci 2012;46:221-9.
8. Seltsam A, Muller TH. UVC irradiation for pathogen reduction of platelet concentrates and plasma. Transfus Med Hemother 2011;38:43-54.
9. Tynngård N, Lindahl T, Ramström S, et al. Effects of different blood components on clot retraction analysed by measuring elasticity with a free oscillating rheometer. Platelets 2006;17:545-54.
10. Tynngård N, Trinks M, Berlin G. Platelet quality after washing: the effect of storage time before washing. Transfusion 2010;50:2745-52.
11. Holme S, Heaton WA, Courtright M. Improved in vivo and in vitro viability of platelet concentrates stored for seven days in a platelet additive solution. Br J Haematol 1987;66:233-8.
12. Tynngård N, Lindahl TL, Trinks M, et al. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods. Transfusion 2008;48:715-22.
13. Seghatchian J, de Sousa G. Pathogen-reduction systems for blood components: the current position and future trends. Transfus Apher Sci 2006;35:189-96.
14. Besaratinia A, Yoon JI, Schroeder C, et al. Wavelength dependence of ultraviolet radiation-induced DNA damage as determined by laser irradiation suggests that cyclobutane pyrimidine dimers are the principal DNA lesions produced by terrestrial sunlight. FASEB J 2011;25:3079-91.
15. van der Meer PF, de Korte D. Platelet preservation: agitation and containers. Transfus Apher Sci 2011;44:297-304.
16. Picker SM, Oustianskaia L, Schneider V, et al. Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction. Vox Sang 2009;97:26-33.
17. Picker SM, Speer R, Gathof BS. Functional characteristics of buffy-coat PLTs photochemically treated with amotosalen-HCl for pathogen inactivation. Transfusion 2004;44:320-9.
18. Johnson L, Winter KM, Reid S, et al. The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover. Vox Sang 2011;101:208-14.
19. Johnson L, Loh YS, Kwok M, et al. In vitro assessment of buffy-coat derived platelet components suspended in SSP+ treated with the INTERCEPT Blood system. Transfus Med 2013;23:121-9.
20. Curvers J, van Pampus EC, Feijge MA, et al. Decreased responsiveness and development of activation markers of PLTs stored in plasma. Transfusion 2004;44:49-58.
21. Metcalfe P, Williamson LM, Reutelingsperger CP, et al. Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods. Br J Haematol 1997;98:86-95.
22. Sandgren P, Callaert M, Shanwell A, et al. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study. Transfusion 2008;48:688-96.
23. Picker SM, Schneider V, Gathof BS. Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies. Transfusion 2009;49:1224-32.
24. Wang C, Mody M, Herst R, et al. Flow cytometric analysis of platelet function in stored platelet concentrates. Transfus Sci 1999;20:129-39.
25. Mohr H, Steil L, Gravemann U, et al. A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Transfusion 2009;49:2612-24.
26. Bashir S, Cookson P, Wiltshire M, et al. Pathogen inactivation of platelets using ultraviolet C light: effect on in vitro function and recovery and survival of platelets. Transfusion 2013;53:990-1000.
27. Verhaar R, Dekkers DW, De Cuyper IM, et al. UV-C irradiation disrupts platelet surface disulfide bonds and activates the platelet integrin alphaIIbbeta3. Blood 2008;112:4935-9.
28. Tynngård N, Trinks M, Berlin G. In vitro properties of platelets stored in three different additive solutions. Transfusion 2012;52:1003-9.
29. Reid TJ, Snider R, Hartman K, et al. A method for the quantitative assessment of platelet-induced clot retraction and clot strength in fresh and stored platelets. Vox Sang 1998;75:270-7.
30. Gutensohn K, Geidel K, Kroeger N, et al. Platelet function testing in apheresis products: flow cytometric, resonance thrombographic (RTG) and rotational thrombelastographic (roTEG) analyses. Transfus Apher Sci 2002;26:147-55.
31. Cauwenberghs S, van Pampus E, Curvers J, et al. Hemostatic and signaling functions of transfused platelets. Transfus Med Rev 2007;21:287-94.
32. Cookson P, Sutherland J, Turner C, et al. Platelet apoptosis and activation in platelet concentrates stored for up to 12 days in plasma or additive solution. Transfus Med 2010;20:392-402.
33. Leytin V, Allen DJ, Mutlu A, et al. Platelet activation and apoptosis are different phenomena: evidence from the sequential dynamics and the magnitude of responses during platelet storage. Br J Haematol 2008;142:494-7.
34. Sandgren P, Tolksdorf F, Struff WG, et al. In vitro effects on platelets irradiated with short-wave ultraviolet light without any additional photoactive reagent using the THERAFLEX UV-Platelets method. Vox Sang 2011;101:35-43.
35. Okada Y, Maeno E, Shimizu T, et al. Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). J Physiol 2001;532:3-16.
36. Kim BK, Baldini MG. The platelet response to hypotonic shock. Its value as an indicator of platelet viability after storage. Transfusion 1974;14:130-8.
37. Holme S, Murphy S. Platelet storage at 22 degrees C for transfusion: interrelationship of platelet density and size, medium pH, and viability after in vivo infusion. J Lab Clin Med 1983;101:161-74.
38. Picker SM, Oustianskaia L, Schneider V, et al. Annexin V release and transmembrane mitochondrial potential during storage of apheresis-derived platelets treated for pathogen reduction. Transfus Med Hemother 2010;37:7-12.
39. Picker SM, Tauszig ME, Gathof BS. Cell quality of apheresis-derived platelets treated with riboflavin-ultraviolet light after resuspension in platelet additive solution. Transfusion 2012;52:510-6.
40. Odink J. Platelet preservation. II. The response of human platelet suspensions to hypotonic stress. Thromb Haemost 1976;36:182-91.
41. VandenBroeke T, Dumont LJ, Hunter S, et al. Platelet storage solution effects on the accuracy of laboratory tests for platelet function: a multi-laboratory study. Vox Sang 2004;86:183-8.
42. 51Cr recovery in vivo of preserved platelets. Transfusion 1974;14:331-7.
43. Holme S, Moroff G, Murphy S. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Transfusion 1998;38:31-40.
44. Slichter SJ, Bolgiano D, Jones MK, et al. Viability and function of 8-day-stored apheresis platelets. Transfusion 2006;46:1763-9.